Clinical Trial Update: An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE [Phase 4]

View source ↗

Summary

This is a completed Phase 4 extension study by Novartis Vaccines to assess how long antibodies against tick-borne encephalitis persist in children and adolescen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• TicoVac (Tick-borne encephalitis vaccine (inactivated))

Snippet

Sponsor: Novartis Vaccines | Conditions: Tick Borne Encephalitis (TBE) | Phase 4 | Status: COMPLETED